Karyopharm Therapeutics
KPTI
KPTI
108 hedge funds and large institutions have $300M invested in Karyopharm Therapeutics in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 42 increasing their positions, 21 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
108
Holders Change
-7
Holders Change %
-6.09%
% of All Funds
2.34%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
19
Increased
42
Reduced
21
Closed
26
Calls
$4.08M
Puts
$1.3M
Net Calls
+$2.78M
Net Calls Change
+$3.12M
Top Buyers
| 1 |
Millennium Management
New York
|
+$13.3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$9M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.17M |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$3.37M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$3.02M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$14.4M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$10.3M |
| 3 |
State Street
Boston,
Massachusetts
|
-$9.11M |
| 4 |
DM
Deerfield Management
New York
|
-$4.45M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.99M |
